PD Dr. med. ID: 49552

Francis Ayuketang Ayuk

graph of relations

Publications

  1. 2018
  2. Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802

    Holtan, S. G., DeFor, T. E., Panoskaltsis-Mortari, A., Khera, N., Levine, J. E., Flowers, M. E. D., Lee, S. J., Inamoto, Y., Chen, G. L., Mayer, S., Arora, M., Palmer, J., Cutler, C. S., Arai, S., Lazaryan, A., Newell, L. F., Jagasia, M. H., Pusic, I., Wood, W. A., Renteria, A. S., Yanik, G., Hogan, W. J., Hexner, E., Ayuk, F., Holler, E., Bunworasate, U., Efebera, Y. A., Ferrara, J. L. M., Pidala, J., Howard, A., Wu, J., Bolaños-Meade, J., Ho, V., Alousi, A., Blazar, B. R., Weisdorf, D. J. & MacMillan, M. L., 14.08.2018, In: BLOOD ADV. 2, 15, p. 1882-1888 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients

    Westhölter, D., Hiller, J., Denzer, U., Polywka, S., Ayuk, F., Rybczynski, M., Horvatits, T., Gundlach, S., Blöcker, J., Schulze Zur Wiesch, J., Fischer, N., Addo, M. M., Peine, S., Göke, B., Lohse, A. W., Lütgehetmann, M. & Pischke, S., 07.2018, In: J HEPATOL. 69, 1, p. 36-42 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. MAGIC biomarkers predict long term outcomes for steroid-resistant acute GVHD

    Major-Monfried, H., Renteria, A. S., Pawarode, A., Reddy, P., Ayuk, F., Holler, E., Efebera, Y. A., Hogan, W. J., Wölfl, M., Qayed, M., Hexner, E. O., Wudhikarn, K., Ordemann, R., Young, R., Shah, J., Hartwell, M. J., Chaudhry, M., Aziz, M., Etra, A., Yanik, G. A., Kröger, N., Weber, D., Chen, Y-B., Nakamura, R., Rösler, W., Kitko, C. L., Harris, A. C., Pulsipher, M., Reshef, R., Kowalyk, S., Morales, G., Torres, I., Özbek, U., Ferrara, J. L. M. & Levine, J. E., 21.06.2018, In: BLOOD. 131, 25, p. 2846-2855 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

    Mathew, N. R., Baumgartner, F., Braun, L., O'Sullivan, D., Thomas, S., Waterhouse, M., Müller, T. A., Hanke, K., Taromi, S., Apostolova, P., Illert, A. L., Melchinger, W., Duquesne, S., Schmitt-Graeff, A., Osswald, L., Yan, K-L., Weber, A., Tugues, S., Spath, S., Pfeifer, D., Follo, M., Claus, R., Lübbert, M., Rummelt, C., Bertz, H., Wäsch, R., Haag, J., Schmidts, A., Schultheiss, M., Bettinger, D., Thimme, R., Ullrich, E., Tanriver, Y., Vuong, G. L., Arnold, R., Hemmati, P., Wolf, D., Ditschkowski, M., Jilg, C., Wilhelm, K., Leiber, C., Gerull, S., Halter, J., Lengerke, C., Pabst, T., Schroeder, T., Kobbe, G., Rösler, W., Doostkam, S., Meckel, S., Stabla, K., Metzelder, S. K., Halbach, S., Brummer, T., Hu, Z., Dengjel, J., Hackanson, B., Schmid, C., Holtick, U., Scheid, C., Spyridonidis, A., Stölzel, F., Ordemann, R., Müller, L. P., Sicre-de-Fontbrune, F., Ihorst, G., Kuball, J., Ehlert, J. E., Feger, D., Wagner, E-M., Cahn, J-Y., Schnell, J., Kuchenbauer, F., Bunjes, D., Chakraverty, R., Richardson, S., Gill, S., Kröger, N., Ayuk, F., Vago, L., Ciceri, F., Müller, A. M., Kondo, T., Teshima, T., Klaeger, S., Kuster, B., Kim, D. D. H., Weisdorf, D., van der Velden, W., Dörfel, D., Bethge, W., Hilgendorf, I., Hochhaus, A., Andrieux, G., Börries, M., Busch, H., Magenau, J., Reddy, P., Labopin, M., Antin, J. H., Henden, A. S., Hill, G. R., Kennedy, G. A., Bar, M., Sarma, A., McLornan, D., Mufti, G., Oran, B., Rezvani, K., Shah, O., Negrin, R. S., Nagler, A., Prinz, M., Burchert, A., Neubauer, A., Beelen, D., Mackensen, A., von Bubnoff, N., Herr, W., Becher, B., Socié, G., Caligiuri, M. A., Ruggiero, E., Bonini, C., Häcker, G., Duyster, J., Finke, J., Pearce, E., Blazar, B. R. & Zeiser, R., 10.04.2018, In: NAT MED. 24, 4, p. 526

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  6. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

    Mathew, N. R., Baumgartner, F., Braun, L., O'Sullivan, D., Thomas, S., Waterhouse, M., Müller, T. A., Hanke, K., Taromi, S., Apostolova, P., Illert, A. L., Melchinger, W., Duquesne, S., Schmitt-Graeff, A., Osswald, L., Yan, K-L., Weber, A., Tugues, S., Spath, S., Pfeifer, D., Follo, M., Claus, R., Lübbert, M., Rummelt, C., Bertz, H., Wäsch, R., Haag, J., Schmidts, A., Schultheiss, M., Bettinger, D., Thimme, R., Ullrich, E., Tanriver, Y., Vuong, G. L., Arnold, R., Hemmati, P., Wolf, D., Ditschkowski, M., Jilg, C., Wilhelm, K., Leiber, C., Gerull, S., Halter, J., Lengerke, C., Pabst, T., Schroeder, T., Kobbe, G., Rösler, W., Doostkam, S., Meckel, S., Stabla, K., Metzelder, S. K., Halbach, S., Brummer, T., Hu, Z., Dengjel, J., Hackanson, B., Schmid, C., Holtick, U., Scheid, C., Spyridonidis, A., Stölzel, F., Ordemann, R., Müller, L. P., Sicre-de-Fontbrune, F., Ihorst, G., Kuball, J., Ehlert, J. E., Feger, D., Wagner, E-M., Cahn, J-Y., Schnell, J., Kuchenbauer, F., Bunjes, D., Chakraverty, R., Richardson, S., Gill, S., Kröger, N., Ayuk, F., Vago, L., Ciceri, F., Müller, A. M., Kondo, T., Teshima, T., Klaeger, S., Kuster, B., Kim, D. D. H., Weisdorf, D., van der Velden, W., Dörfel, D., Bethge, W., Hilgendorf, I., Hochhaus, A., Andrieux, G., Börries, M., Busch, H., Magenau, J., Reddy, P., Labopin, M., Antin, J. H., Henden, A. S., Hill, G. R., Kennedy, G. A., Bar, M., Sarma, A., McLornan, D., Mufti, G., Oran, B., Rezvani, K., Shah, O., Negrin, R. S., Nagler, A., Prinz, M., Burchert, A., Neubauer, A., Beelen, D., Mackensen, A., von Bubnoff, N., Herr, W., Becher, B., Socié, G., Caligiuri, M. A., Ruggiero, E., Bonini, C., Häcker, G., Duyster, J., Finke, J., Pearce, E., Blazar, B. R. & Zeiser, R., 03.2018, In: NAT MED. 24, 3, p. 282-291 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Langzeitnachsorge von Patienten nach allogener Blutstammzelltransplantation

    Ayuketang, F. A. & Kroger, N., 2018, Langzeitnachsorge von Patienten nach allogener Blutstammzelltransplantation. Ayuk, F., Kröger, N. & Tichelli, A. (eds.). 1. ed. Uni-Med

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  8. 2017
  9. Impact of molecular residual disease post allografting in myelofibrosis patients

    Wolschke, C., Badbaran, A., Zabelina, T., Christopeit, M., Ayuketang, F. A., Triviai, I., Zander, A., Alchalby, H., Bacher, U., Fehse, B. & Kröger, N-M., 11.2017, In: BONE MARROW TRANSPL. 52, 11, p. 1526-1529

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation

    Kröger, N., Panagiota, V., Badbaran, A., Zabelina, T., Triviai, I., Araujo Cruz, M. M., Shahswar, R., Ayuketang, F. A., Gehlhaar, M., Wolschke, C., Bollin, R., Walter, C., Dugas, M., Wiehlmann, L., Lehmann, U., Koenecke, C., Chaturvedi, A., Alchalby, H., Stadler, M., Eder, M., Christopeit, M., Göhring, G., Koenigsmann, M., Schlegelberger, B., Kreipe, H-H., Ganser, A., Stocking, C., Fehse, B., Thol, F. & Heuser, M., 07.2017, In: BIOL BLOOD MARROW TR. 23, 7, p. 1095-1101

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. An early-biomarker algorithm predicts lethal graft-versus-host disease and survival

    Hartwell, M. J., Özbek, U., Holler, E., Renteria, A. S., Major-Monfried, H., Reddy, P., Aziz, M., Hogan, W. J., Ayuketang, F., Efebera, Y. A., Hexner, E. O., Bunworasate, U., Qayed, M., Ordemann, R., Wölfl, M., Mielke, S., Pawarode, A., Chen, Y-B., Devine, S., Harris, A. C., Jagasia, M., Kitko, C. L., Litzow, M. R., Kröger, N., Locatelli, F., Morales, G., Nakamura, R., Reshef, R., Rösler, W., Weber, D., Wudhikarn, K., Yanik, G. A., Levine, J. E. & Ferrara, J. L. M., 09.02.2017, In: JCI INSIGHT. 2, 3, p. e89798

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. 2016
  13. Potent in vitro and in vivo effects of polyclonal anti-human-myeloma globulins

    Schieferdecker, A., Shoshani, O., Westner, B., Zipori, D., Fehse, B., Kröger, N. & Ayuketang, F. A., 11.10.2016, In: ONCOTARGET. 7, 41, p. 67061-67070

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Late acute graft versus host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

    Holtan, S. G., Khera, N., Levine, J. E., Chai, X., Storer, B., Liu, H. D., Inamoto, Y., Chen, G. L., Mayer, S., Arora, M., Palmer, J., Flowers, M. E. D., Cutler, C. S., Lukez, A., Arai, S., Lazaryan, A., Newell, L. F., Krupski, C., Jagasia, M. H., Pusic, I., Wood, W., Renteria, A. S., Yanik, G., Hogan, W. J., Hexner, E., Ayuketang, F. A., Holler, E., Watanaboonyongcharoen, P., Efebera, Y. A., Ferrara, J. L. M., Panoskaltsis-Mortari, A., Weisdorf, D., Lee, S. J. & Pidala, J., 10.2016, In: BLOOD. 128, 19, p. 2350-2358

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Serial 18F-FDG PET for Monitoring Treatment Response After Allogeneic Stem Cell Transplantation for Myelofibrosis

    Derlin, T., Alchalby, H., Bannas, P., Laqmani, A., Ayuketang, F. A., Triviai, I., Kreipe, H-H., Bengel, F. M. & Kröger, N-M., 10.2016, In: J NUCL MED. 57, 10, p. 1556-1559 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis

    Christopeit, M., Badbaran, A., Zabelina, T., Zeck, G., Fehse, B., Ayuketang, F. A., Wolschke, C. & Kröger, N-M., 10.2016, In: BONE MARROW TRANSPL. 51, 10, p. 1391-1393 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Correlation of somatic mutations with outcome after FLAMSA-busulfan sequential conditioning and allogeneic stem cell transplantation in patients with MDS

    Christopeit, M., Badbaran, A., Alawi, M., Zabelina, T., Zeck, G., Wolschke, C., Ayuketang, F. A. & Kröger, N., 01.09.2016, In: EUR J HAEMATOL. 97, 3, p. 288-96

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

    Alchalby, H., Yunus, D-R., Zabelina, T., Ayuketang, F. A. & Kröger, N-M., 09.2016, In: BONE MARROW TRANSPL. 51, 9, p. 1223-7 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Outcome after Transplantation According to Reduced-Intensity Conditioning Regimen in Patients Undergoing Transplantation for Myelofibrosis

    Robin, M., Porcher, R., Wolschke, C., Sicre de Fontbrune, F., Alchalby, H., Christopeit, M., Cassinat, B., Zabelina, T., Peffault de Latour, R., Ayuketang, F. A., Socié, G. & Kröger, N., 07.2016, In: BIOL BLOOD MARROW TR. 22, 7, p. 1206-11 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Blood-borne Hepatitis E Virus Transmission: A Relevant Risk for Immunosuppressed Patients

    Pischke, S., Hiller, J., Lütgehetmann, M., Polywka, S., Rybczynski, M., Ayuketang, F. A. & Lohse, A. W., 13.05.2016, In: CLIN INFECT DIS. 63, 4, p. 569-570 2 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  21. Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

    Kröger, N., Solano, C., Wolschke, C., Bandini, G., Patriarca, F., Pini, M., Nagler, A., Selleri, C., Risitano, A., Messina, G., Bethge, W., Pérez de Oteiza, J., Duarte, R., Carella, A. M., Cimminiello, M., Guidi, S., Finke, J., Mordini, N., Ferra, C., Sierra, J., Russo, D., Petrini, M., Milone, G., Benedetti, F., Heinzelmann, M., Pastore, D., Jurado, M., Terruzzi, E., Narni, F., Völp, A., Ayuketang, F. A., Ruutu, T. & Bonifazi, F., 07.01.2016, In: NEW ENGL J MED. 374, 1, p. 43-53 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

    Harris, A. C., Young, R., Devine, S., Hogan, W. J., Ayuketang, F. A., Bunworasate, U., Chanswangphuwana, C., Efebera, Y. A., Holler, E., Litzow, M., Ordemann, R., Qayed, M., Renteria, A. S., Reshef, R., Wölfl, M., Chen, Y-B., Goldstein, S., Jagasia, M., Locatelli, F., Mielke, S., Porter, D., Schechter, T., Shekhovtsova, Z., Ferrara, J. L. M. & Levine, J. E., 01.2016, In: BIOL BLOOD MARROW TR. 22, 1, p. 4-10 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. 2015
  24. Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)

    Kröger, N., Bornhäuser, M., Stelljes, M., Pichlmeier, U., Trenschel, R., Schmid, C., Arnold, R., Martin, H., Heinzelmann, M., Wolschke, C., Meyer, R. G., Bethge, W., Kobbe, G., Ayuketang, F. A., Gökbuget, N., Hölzer, D., Zander, A. & Beelen, D., 12.2015, In: BONE MARROW TRANSPL. 50, 12, p. 1503-7 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria

    Ayuketang, F. A., Veit, R., Zabelina, T., Bussmann, L., Christopeit, M., Alchalby, H., Wolschke, C., Lellek, H., Bacher, U., Zander, A. R. & Kröger, N., 10.2015, In: ANN HEMATOL. 94, 10, p. 1727-32 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    Zeiser, R., Burchert, A., Lengerke, C., Verbeek, M., Maas-Bauer, K., Metzelder, S. K., Spoerl, S., Ditschkowski, M., Ecsedi, M., Sockel, K., Ayuketang, F. A., Ajib, S., de Fontbrune, F. S., Na, I-K., Penter, L., Holtick, U., Wolf, D., Schuler, E., Meyer, E., Apostolova, P., Bertz, H., Marks, R., Lübbert, M., Wäsch, R., Scheid, C., Stölzel, F., Ordemann, R., Bug, G., Kobbe, G., Negrin, R., Brune, M., Spyridonidis, A., Schmitt-Gräff, A., van der Velden, W., Huls, G., Mielke, S., Grigoleit, G. U., Kuball, J., Flynn, R., Ihorst, G., Du, J., Blazar, B. R., Arnold, R., Kröger, N., Passweg, J., Halter, J., Socié, G., Beelen, D., Peschel, C., Neubauer, A., Finke, J., Duyster, J. & von Bubnoff, N., 10.2015, In: LEUKEMIA. 29, 10, p. 2062-8 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Stammzelltransplantation bei Multipler Sklerose. Hamburger Erfahrungen und internationaler Forschungsstand

    Stellmann, J-P., Stürner, K. H., Ufer, F., Havemeister, S., Pöttgen, J., Ayuketang, F. A., Kröger, N., Friese, M. A. & Heesen, C., 08.2015, In: NERVENARZT. 86, 8, p. 989-96 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Magnetic resonance enterography for assessment of intestinal graft-versus-host disease after allogeneic stem cell transplantation

    Derlin, T., Laqmani, A., Veldhoen, S., Apostolova, I., Ayuketang, F. A., Adam, G., Kröger, N. & Bannas, P., 05.2015, In: EUR RADIOL. 25, 5, p. 1229-1237

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.

    Mendorf, A., Klyuchnikov, E., Langebrake, C., Rohde, H., Ayuketang, F. A., Regier, M., Christopeit, M., Zabelina, T., Bacher, A., Stübig, T., Wolschke, C., Bacher, U. & Kroger, N., 2015, In: ACTA HAEMATOL-BASEL. 134, 3, p. 146-154

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. 2014
  31. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

    Stübig, T., Alchalby, H., Ditschkowski, M., Wolf, D., Wulf, G., Zabelina, T., Wolschke, C., Ayuketang, F. A. & Kröger, N., 01.08.2014, In: LEUKEMIA. 28, 8, p. 1736-8 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis

    Kröger, N., Zabelina, T., Alchalby, H., Stübig, T., Wolschke, C., Ayuketang, F. A., von Huenerbein, N., Kvasnicka, H-M., Thiele, J., Kreipe, H-H. & Büsche, G., 01.06.2014, In: BIOL BLOOD MARROW TR. 20, 6, p. 812-5 4 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Serum albumin level predicts survival of patients with gastrointestinal acute graft-versus-host disease after allogeneic stem cell transplantation

    Ayuketang, F. A., Bussmann, L., Zabelina, T., Veit, R., Alchalby, H., Wolschke, C., Lellek, H., Bacher, U., Zander, A. R. & Kröger, N., 01.05.2014, In: ANN HEMATOL. 93, 5, p. 855-61 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines

    Nitsch, E., Mina, S., Brammer, I., Pace, A., Schuch, G., Bokemeyer, C., Zander, A., Kröger, N-M. & Ayuketang, F. A., 01.04.2014, In: ANTICANCER RES. 34, 4, p. 1779-84 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies

    Klyuchnikov, E., El-Cheikh, J., Sputtek, A., Lioznov, M., Calmels, B., Furst, S., Chabannon, C., Crocchiolo, R., Lemarié, C., Faucher, C., Bacher, U., Alchalby, H., Stübig, T., Wolschke, C., Ayuketang, F. A., Reckhaus, M-L., Blaise, D. & Kröger, N-M., 01.03.2014, In: BIOL BLOOD MARROW TR. 20, 3, p. 382-6 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

    Fu, Y., Schroeder, T., Zabelina, T., Badbaran, A., Bacher, U., Kobbe, G., Ayuketang, F. A., Wolschke, C., Schnittger, S., Kohlmann, A., Haferlach, T. & Kröger, N., 01.03.2014, In: EUR J HAEMATOL. 92, 3, p. 189-94 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation

    Wolschke, C., Zabelina, T., Ayuketang, F. A., Alchalby, H., Berger, J., Klyuchnikov, E., Pein, U-M., Schumacher, S., Amtsfeld, G., Adjallé, R., Wortmann, F., Lellek, H., Randenborgh, A., Zander, A. & Kröger, N., 01.01.2014, In: BONE MARROW TRANSPL. 49, 1, p. 126-30 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. 2013
  39. Impact of physiological BM CD10+CD19+ B-cell precursors (haematogones) in the post-transplant period in patients with AML

    Christopeit, M., Heiland, A., Binder, M., Zabelina, T., Ayuketang, F. A., Horn, C., Haferlach, T., Bokemeyer, C., Kröger, N. & Bacher, U., 01.09.2013, In: BONE MARROW TRANSPL. 48, 9, p. 1257-9 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  40. Donor choice according to age for allo-SCT for AML in complete remission

    Ayuketang, F. A., Zabelina, T., Wortmann, F., Alchalby, H., Wolschke, C., Lellek, H., Bacher, U., Zander, A. & Kröger, N., 01.08.2013, In: BONE MARROW TRANSPL. 48, 8, p. 1028-32 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase

    Langer, F., Spath, B., Fischer, C., Stolz, M., Ayuketang, F. A., Kröger, N-M., Bokemeyer, C. & Ruf, W., 21.03.2013, In: BLOOD. 121, 12, p. 2324-35 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Evaluation of BM cytomorphology after allo-SCT in patients with MDS

    Christopeit, M., Ocheni, S., Haferlach, T., Miersch, K., Zabelina, T., Klyuchnikov, E., Binder, M., Ayuketang, F. A., Schafhausen, P., Zander, A. R., Bokemeyer, C., Kröger, N. & Bacher, U., 01.03.2013, In: BONE MARROW TRANSPL. 48, 3, p. 465-6 2 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  43. Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.

    Kröger, N-M., Badbaran, A., Zabelina, T., Ayuketang, F. A., Wolschke, C., Alchalby, H., Klyuchnikov, E., Atanackovic, D., Schilling, G., Hansen, T., Schwarz, S., Heinzelmann, M., Zeschke, S., Bacher, U., Stübig, T., Fehse, B. & Zander, A. R., 2013, In: BIOL BLOOD MARROW TR. 19, 3, p. 398-404 7 p., 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

    Oyekunle, A., Zander, A. R., Binder, M., Ayuketang, F. A., Zabelina, T., Christopeit, M., Stübig, T., Alchalby, H., Schafhausen, P., Lellek, H., Wolschke, C., Müller, I., Bacher, U. & Kröger, N-M., 2013, In: ANN HEMATOL. 92, 4, p. 487-496 10 p., 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

    Wolschke, C., Stübig, T., Hegenbart, U., Schönland, S., Heinzelmann, M., Hildebrandt, Y., Ayuketang Ayuk, F., Atanackovic, D., Dreger, P., Zander, A. & Kröger, N., 2013, In: EXP HEMATOL. 41, 2, p. 133-134 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.

    Kröger, N., Zabelina, T., Klyuchnikov, E., Kropff, M., Pflüger, K-H., Burchert, A., Stübig, T., Wolschke, C., Ayuketang, F. A., Hildebrandt, Y., Bacher, U., Badbaran, A., Schilling, G., Hansen, T., Atanackovic, D. & Zander, A. R., 2013, In: BONE MARROW TRANSPL. 48, 3, p. 403-407 5 p., 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. 2012
  48. Evaluation of BM cytomorphology after allo-SCT in patients with AML

    Christopeit, M., Miersch, K., Klyuchnikov, E., Haferlach, T., Binder, M., Zabelina, T., Ayuketang Ayuk, F., Schafhausen, P., Zander, A. R., Bokemeyer, C., Kröger, N. & Bacher, U., 12.2012, In: BONE MARROW TRANSPL. 47, 12, p. 1538-1544 7 p., 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.

    Alchalby, H., Yunus, D-R., Zabelina, T., Kobbe, G., Holler, E., Bornhäuser, M., Schwerdtfeger, R., Bethge, W., Kvasnicka, H. M., Büsche, G., Ayuketang Ayuk, F., Bacher, U., Zander, A. R. & Kröger, N., 2012, In: BRIT J HAEMATOL. 157, 1, p. 75-85 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. 2011
  51. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation

    Klyuchnikov, E., Sputtek, A., Slesarchuk, O., Lioznov, M., Stübig, T., Bacher, U., Amtsfeld, G., Merle, E., Reckhaus, M-L., Fehse, B., Wolschke, C., Adjalle, R., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 01.03.2011, In: BIOL BLOOD MARROW TR. 17, 3, p. 374-383 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.

    Lellek, H., Waldenmaier, D., Dahlke, J., Ayuketang Ayuk, F., Wolschke, C., Kröger, N. & Zander, A. R., 2011, In: MYCOSES. 54, 1, p. 39-44 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.

    Alchalby, H., Lioznov, M., Fritzsche-Friedland, U., Badbaran, A., Zabelina, T., Bacher, U., Stübig, T., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2011, In: BONE MARROW TRANSPL. 47, 1, p. 143-145 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

    Wolff, D., Schleuning, M., von Harsdorf, S., Bacher, U., Gerbitz, A., Stadler, M., Ayuketang Ayuk, F., Kiani, A., Schwerdtfeger, R., Vogelsang, G. B., Kobbe, G., Gramatzki, M., Lawitschka, A., Mohty, M., Pavletic, S. Z., Greinix, H. & Holler, E., 2011, In: BIOL BLOOD MARROW TR. 17, 1, p. 1-17 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

    Kröger, N., Zabelina, T., Berger, J., Duske, H., Klyuchnikov, E., Binder, T., Stübig, T., Hildebrandt, Y., Atanackovic, D., Alchalby, H., Ayuketang Ayuk, F., Zander, A. R., Bacher, U. & Eiermann, T., 2011, In: LEUKEMIA. 25, 10, p. 1657-1661 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.

    Klyuchnikov, E., Bacher, U., Kröger, N., Kazantsev, I., Zabelina, T., Ayuketang Ayuk, F. & Zander, A. R., 2011, In: ANN HEMATOL. 2011, p. 974658

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review